![Ulf Sewerin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Ulf Sewerin is currently the Chief Executive Officer at AddBIO AB since 2012.
Prior to this, he worked as a Director at Doxa AB.
Actieve functies van Ulf Sewerin
Bedrijven | Functie | Begin |
---|---|---|
AddBIO AB
![]() AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Algemeen Directeur | 31-08-2012 |
Eerdere bekende functies van Ulf Sewerin
Bedrijven | Functie | Einde |
---|---|---|
DOXA AB | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DOXA AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
AddBIO AB
![]() AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |